A recombinant fragment of human SP-D (rfhSP-D) decreases the motility and proliferation of ovarian cancer cells by inhibiting the mammalian target of rapamycin (mTOR) activity, increasing caspase 3 cleavage, and inducing pro-apoptotic genes Fas and TNF-α [120]. Here, MTOR is linked to ovarian cancer.